APOE ε4 and Alzheimer's disease: Positive association in a Colombian clinical series and review of the Latin-American studies

Arquivos de Neuro-Psiquiatria

Volumn 59, Issue 1, 2001, Pages 11-17

  Jacquier, Martine ^a,b   Arango, Diana ^c   Villareal, Elsa ^a   Torres, Orlando ^a,b   Serrano, Martha Lucia ^a   Cruts, Marc ^c   Montañes, Patricia ^b   Cano, Carlos ^b   Rodriguez, Maria Nelcy ^b   Serneels, Sally ^c   Van Broeckhoven, Christine ^c  

^a INSTITUTO NACIONAL DE SALUD   (Colombia)

^b PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Alzheimer's disease; APOE; Colombia; Dementia; Ethnic groups; Risk factors

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

AGED; ALZHEIMER DISEASE; CASE CONTROL STUDY; COLOMBIA; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC MARKER; GENETICS; GENOTYPE; HUMAN; MALE; ONSET AGE; REVIEW; SOUTH AND CENTRAL AMERICA;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; COLOMBIA; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HUMANS; LATIN AMERICA; MALE;

EID: 0035288137     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2001000100004     Document Type: Article

References (38)

1. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923
2. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 1997;278:1349-1356.
3. Morelli L, Leoni J, Castaño EM, Mangone CA, Lambierto A. Apoliporotein E polymorphism and late-onset Alzheimer's disease in Argentina. JNNP 1996;61:426-427.
4. Quiroga P, Calvo C, Albala C, et al. Apolipoprotein E polymorphism in elderly Chilean people with Alzheimer's disease. Neuroepidemiology 1999;18:48-52.
5. McKahn G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Workgroup on Alzheimer's disease. Neurology 1994;24:939-944.
6. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;3:12-15 .
7. Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-1159.
8. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein E4 allele in patients with Alzheimer's disease. Ann Neurol 1993;34:752-754.
9. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease;ethnic variation in genotypic risks. Ann Neurol 1995;37:254-259.
10. Tang MX, Maestre G, Tsai WY, et al. Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease. Ann NY Acad Sci 1996;802:6-15.
11. Payami H, Zareparsi S, Montee KR, et al. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease;a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet 1996;58:803-811.
12. Barker W, Mullan M, St George Hyslop P. The APOE -E4 allele and Alzheimer Disease among African American, Hispanics and White. JAMA 1998;280:1661-1662.
13. Tang MX, Stern Y, Marder K et al. The APOE-e4 allele and the risk of Alzheimer disease among African Americans, whites, and hispanics. JAMA 1998;279:751-755.
14. Mendez HA. The APOE-epsilon 4 allele in Alzheimer disease among African American, Hispanics and whites. JAMA 1998;280:1663.
15. Adroer R, Santacruz P, Blesa R, Lopez-Pousa S, Ascaso C, Oliva R. Apolipoprotein E4 allele frequency in Spanish Alzheimer and control cases. Neurosci-Lett 1995;189:182-186.
16. López OL, Lopez-Pousa S, Kamboh MI, et al. Apolipoprotein E polymorphism in Alzheimer's disease: a comparison of 2 research populations from Spain and the United States. Eur Neurol 1998;39:229-233.
17. Strittmatter WJ, Weisgraber KH, Huang DY, et al. Binding of human apolipoprotein E to synthetic amyloid beta-peptide;isoform specific effects and implications for late-onset Alzheimer's disease. Proc Natl Acad Sci 1993;90:8098-8102.
18. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
19. Lannfelt L, Lilius L, Nastase M, et al. Lack of association between apolipoprotein E and sporadic Alzheimer's disease. Neurosci Lett. 1994;169:175-178.
20. Duara R, Barker WW, Lopez-Alberola BS, et al. A comparison of familial and sporadic Alzheimer's disease. Neurology 1993;43:1377-1384.
21. Slooter AJ, Cruts M, Kalmijn S, et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study;the Rotterdam Study. Arch Neurol 1998;7:964-968.
22. Duara R, Barker WW, Lopez-Alberola R, et al. Alzheimer's disease ;interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity and age of onset. Neurology 1996;46:1575-1579.
23. Corder EH, Lannfelt L, Bogdanovic N, Fratiglioni L, Mori H. The role of the APOE polymorphisms in late-onset dementias. Cell Mol Life Sci 1998;54:928-934.
24. Devi G, Ottman R, Tang M, et al.. Influence of APOE genotype on familial aggregation of AD in an urban population. Neurology 1999;53:789-794.
25. Tsuang D, Kukull W, Sheppard L et al. Impact of sample selection on APOE epsilon 4 allele frequency;a comparison of two Alzheimer's disease samples. J Am Geriatr Soc 1996;44:704-707.
26. Saunders AM, Hulette C, Welsh-Bohmer KA et al. Specificity, sensitivity and predictive value of apoliprotein E genotyping for sporadic Alzheimer's disease. Lancet 1996;348:90-93.
27. Lendon CL, Martinez A, Behrens IM, et al. E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles. Hum Mutat 1997;10:186-195.
28. Duarte D, Mato J, Moreno M, Yance L. Genotyping of persons affected of familial Alzheimer's disease and first degree relatives with reference to APOE . Alzheimer's Dis Rev 1998;3:91-94.
29. Almeida OP, Shimokomaki CM . Apolipoprotein E4 and Alzheimer's disease in Sao Paulo-Brazil. Arq Neuropsiquiatr 1997;55:1-7.
30. Oliveira JR, Lima Filho JL, Shimokomaki CM, et al. The use of apolipoprotein E genotype for preclinical detection of risk groups for Alzheimer's disease. Am J Med Genet 1997;74:216-217.
31. Andrade FM, Larrandaburu M, Callegari-Jacques SM, Gastaldo G, Hutz MH. Association of apolipoprotein E polymorphism with plasma lipids and Alzheimer's disease in a southern Brazilian population. Braz J Med Biol Res 2000;33:529-537
32. Harwood DG, Barker WW, Loewenstein DA et al. A cross-ethnic analysis of risk factors for AD in white Hispanics and White non Hispanics. Neurology 1999;52:551-556.
33. Chartier-Harlin MC, Parfitt M, Legrain S et al. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease;analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994;3:569-574.
34. van Djuin CM, de Kniff P, Wehnert A, De Voecht J, Bronzova JB. The apolipoprotein E e2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol 1995;37:605-610.
35. Aguilar CA, Talavera, G., Ordovas JM, et al. The apolipoprotein e4 allele is not associated with an abnormal lipid profile in a Native American population following its traditional lifestyle. Atherosclerosis 1999;142:409-414.
36. Scacchi R, Corbo RM, Rickards O, Mantuano E, Guevara A, De Stefano GF. Apolipoprotein B and E genetic polymorphisms in the Cayapa Indian of Ecuador. Hum Biol 1997;69:375-382.
37. Jaramillo Correa JP, Keyeux G, Ruiz García M, Rodas C, Bernal J. Population study of the APOE, APOC (3′VNTR) and ACE in some Black and Amerindian communities from Colombia. Human Heredity (in press).
38. Combarros O, Leno C, Oterino A, et al. Gender effect on apolipoprotein E epsilon4 allele-associated risk for sporadic Alzheimer's disease. Acta Neurol Scand 1998;97:68-71.